CompaniesBioMarck Pharmaceuticals

BioMarck Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

3

As Collaborator

0

Total Enrollment

270

By Phase

PHASE2: 3

By Status

COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Today
NCT03202394
Hover over trial bars to see details

Recent Trials

NCT03472053Lead Sponsor
A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer
PHASE2Completed
60 participants
Started: Feb 1, 2018 · Completed: Dec 30, 2019
NCT03202394Lead Sponsor
Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS
PHASE2Completed
38 participants
Started: Aug 5, 2017 · Completed: Jun 15, 2020
NCT00648245Lead Sponsor
Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPD
PHASE2Completed
172 participants
Started: Jun 30, 2008 · Completed: Jul 31, 2010